Benjamin Besse
Institut Gustave Roussy(FR)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Lung Cancer Research Studies, Cancer Immunotherapy and Biomarkers, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer(2013)3,387 cited
- → Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials(2019)1,690 cited
- → Sotorasib for Lung Cancers with KRAS p.G12C Mutation(2021)1,682 cited
- → Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer(2012)1,405 cited
- → Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial(2017)1,350 cited
- → Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry(2019)1,334 cited
- → Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer(2018)1,035 cited
- → Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)(2016)972 cited
- → Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer(2018)934 cited
- → Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial(2016)871 cited